BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31714671)

  • 1. p16/Ki-67 immunostaining in the triage of young women with LSIL, ASC-US, and ASC-H cytology.
    Dovnik A; Repše-Fokter A
    Diagn Cytopathol; 2020 Jan; 48(1):96-97. PubMed ID: 31714671
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Celewicz A; Celewicz M; Wężowska M; Chudecka-Głaz A; Menkiszak J; Urasińska E
    Pol J Pathol; 2018; 69(1):42-47. PubMed ID: 29895125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
    Peeters E; Wentzensen N; Bergeron C; Arbyn M
    Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
    Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
    Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL; Dye T; Grace C; Hiraoka M
    J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
    Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
    Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
    Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
    Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+.
    Stănculescu R; Brătilă E; Bauşic V; Vlădescu T
    Rom J Morphol Embryol; 2013; 54(4):1061-5. PubMed ID: 24399002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.
    Chen CC; Huang LW; Bai CH; Lee CC
    Ann Saudi Med; 2016; 36(4):245-51. PubMed ID: 27478909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
    Benevolo M; Mancuso P; Allia E; Gustinucci D; Bulletti S; Cesarini E; Carozzi FM; Confortini M; Bisanzi S; Rubino T; Rollo F; Marchi N; Farruggio A; Pusiol T; Venturelli F; Giorgi Rossi P;
    Cancer Cytopathol; 2021 May; 129(5):383-393. PubMed ID: 33142029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.